Diabetes mellitus and the kidney in adolescents

Adolescent Medicine Clinics

Volumn 16, Issue 1, 2005, Pages 173-184

  Ellis, Eileen N ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; GLOMERULUS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PUBERTY; REVIEW;

ADOLESCENT; ALBUMINURIA; BASEMENT MEMBRANE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY GLOMERULUS; PUBERTY;

EID: 10944226432     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.09.006     Document Type: Review

References (46)

1. K.R. Moore, T.S. Harwell, and J.M. McDowall Three-year prevalence and incidence of diabetes among American Indian youth in Montana and Wyoming, 1999 to 2001 J Pediatr 143 2003 368 371
2. A. Fagot-Campagna, D.J. Pettitt, and M.M. Engelgau Type I diabetes among North American children and adolescents: an epidemiologic review and a public health perspective J Pediatr 136 2000 664 672
3. R. Sinha, G. Fisch, and B. Teague Prevalence of impaired glucose tolerance among children and adolescents with marked obesity N Engl J Med 346 2002 802 810
4. J.D. Nesmith Type II diabetes mellitus in children and adolescents Pediatr Rev 22 2001 147 151
5. A.S. Krolewski, J.H. Warram, and A.R. Christlieb The changing natural history of nephropathy in type I diabetes Am J Med 78 1985 785 794
6. J.N. Kostraba, J.S. Dorman, and T.J. Orchard Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects Diabetes Care 12 1989 686 693
7. R.P. Murphy, M. Nanda, and L. Plotnick The relationship of puberty to diabetic retinopathy Arch Ophthal 108 1990 215 218
8. R.W. Holl, D. Lang, and M. Grabert Diabetic retinopathy in pediatric patients with type I diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control J Pediatr 132 1998 790 794
9. K. Drummond, and M. Mauer The early natural history of nephropathy in type I diabetes. II. Early renal structural changes in type I diabetes Diabetes 51 2002 1580 1587
10. E.N. Ellis, B.A. Warady, and E.G. Wood Renal structural-functional relationships in early diabetes mellitus Pediatr Nephrol 11 1997 584 591
11. B.M. Chavers, R.W. Bilous, and E.N. Ellis Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria N Engl J Med 320 1989 966 970
12. J.J. Cook, and D. Daneman Microalbuminuria in adolescents with insulin-dependent diabetes mellitus Am J Dis Child 144 1990 232 237
13. G. Dahlquist, and S. Rudberg The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty Acta Pediatr Scand 76 1987 795 800
14. E.R. Mathiesen, N. Saurbrey, and E. Hommel Prevalence of microalbuminuria in children with type I (insulin-dependent) diabetes mellitus Diabetologia 29 1986 640 643
15. T. Quattrin, W.R. Waz, and L.C. Duffy Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus Clin Pediatr (Phila) 34 1995 12 17
16. R.W. Holl, M. Grabert, and A. Thon Urinary excretion of albumin in adolescents with type I diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control Diabetes Care 22 1999 1555 1560
17. F. Chiarelli, A. Verrotti, and G. Morgese Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children Pediatr Nephrol 9 1995 154 158
18. C.J. Schultz, H.A.W. Neil, and R.N. Dalton Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type I diabetes Diabetes Care 23 2000 1811 1815
19. B.A. Perkins, L.H. Ficociello, and K.H. Silva Regression of microalbuminuria in type I diabetes N Engl J Med 348 2003 2285 2293
20. D. Gorman, E. Sockett, and D. Daneman The natural history of microalbuminuria in adolescents with type I diabetes J Pediatr 134 1999 333 337
21. S. Rudberg, and G. Dahlquist Determinants of progress of microalbuminuria in adolescents with IDDM Diabetes Care 19 1996 369 371
22. J.R. Sowers, M. Epstein, and E.D. Frohlich Diabetes, hypertension, and cardiovascular disease Hypertension 37 2001 1053 1059
23. H.P. Hansen, P. Hovind, and B.R. Jensen Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy Kidney Int 61 2002 163 168
24. E. Lurbe, J. Redon, and J.M. Pascual The spectrum of circadian blood pressure changes in type I diabetic patients J Hypertens 19 2001 1421 1428
25. W.V. Moore, D.L. Donaldson, and A.M. Chonko Ambulatory blood pressure in type I diabetes mellitus Diabetes 41 1992 1035 1041
26. E.B. Sochett, I. Poon, and W. Balfe Ambulatory blood pressure monitoring in insulin-dependent diabetes mellitus adolescents with and without microalbuminuria J Diabetes Complications 12 1998 18 23
27. E. Lurbe, J. Redon, and A. Kesani Increase in nocturnal blood pressure and progression to microalbuminuria in type I diabetes N Engl J Med 347 2002 797 805
28. C.A. Brosnan, J.C. Meininger, and P.R. Swank Blood pressure profiles in adolescents with recently diagnosed type 2 diabetes Diabetes Care 25 2002 2354
29. K.E. White, and R.W. Bilous Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease J Am Soc Nephrol 11 2000 1667 1673
30. U.B. Berg, T.B. Torbjornsdotter, and G. Jaremko Kidney and morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM Diabetologia 41 1998 1047 1056
31. S. Rudberg, R. Osterby, and G. Dahlquist Predictors of renal morphological changes in early stage of microalbuminuria in adolescents with IDDM Diabetes Care 20 1997 256 271
32. Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial J Pediatr 125 1994 177 188
33. Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group Effect of intensive therapy on the microvascular complications of type I diabetes mellitus JAMA 287 2002 2563 2569
34. Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group Beneficial effect of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT) J Pediatr 139 2001 804 812
35. H.J. Bangstad, R. Osterby, and K. Dahl-Jorgensen Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy Diabetologia 37 1994 483 490
36. B.S. Levine, B.J. Anderson, and D.A. Butler Predictors of glycemic control and short-term adverse outcomes in youth with type I diabetes J Pediatr 139 2001 197 203
37. H.H. Parving Diabetic nephropathy: prevention and treatment Kidney Int 60 2001 2041 2055
38. C.E. Mogensen, S. Neldam, and I. Tikkanen Role of dual blockade of the rennin-angiotensin system in hypertensive, microalbuminuria, non-insulin dependent diabetes: the Calm Study BMJ 321 2000 1440 1444
39. E.J. Lewis, L.G. Hunsicker, and R.P. Bain The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
40. H.H. Parving, P. Rossing, and E. Hommel Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience Am J Kidney Dis 26 1995 99 107
41. S. Andersen, L. Tarnow, and P. Rossing Renoprotective effects of angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy Kidney Int 57 2000 601 606
42. B.M. Brenner, M.E. Cooper, and D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861 869
43. H.H. Parving, H. Lahnert, and J. Brochner-Mortensen The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 2001 870 878
44. P. Jacobsen, S. Andersen, and K. Rossing Dual blockade of the rennin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy Kidney Int 63 2003 1874 1880
45. G.L. Bakris, M. Williams, and L. Dworkin Preserving renal function in adults with hypertension and diabetes: a consensus approach Am J Kidney Dis 36 2000 646 661
46. S. Rudberg, R. Osterby, and H.J. Bangstad Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuria patients with Type I (insulin dependent) diabetic mellitus Diabetologia 42 1999 589 595